Barriers and enablers to evidence-based practice for the initial management of women with early pregnancy bleeding in the Emergency Department
Abstract
BACKGROUND
Women with early pregnancy bleeding experience care variations. We developed a guideline based on best available evidence to guide Emergency Department (ED) management.
AIM
To identify the barriers and enablers to the use of an evidence-based guideline for initial management of women with early pregnancy bleeding in the ED.
METHODS
A mixed methods survey was distributed to 476 staff from four EDs and one Urgent Care Centre, across a health district. Quantitative data were analysed using jamovi (version 2.3.28) and qualitative data were coded and grouped into subcategories and categories. Enablers and barriers were identified, and quantitative and qualitative results were integrated.
FINDINGS
One hundred and four staff completed the survey (response rate 21.8%). Two barriers to evidence-based practice were identified: knowledge and training gap; and ED resources and workload. Two enablers: ED clinician belief about appropriateness of care; and women are willing to stay, wait and/or request care. Two functioned as both enablers and barriers: guideline is available, however elements are absent or not applicable; and ED clinicians are confident in some but not all aspects of care.
CONCLUSION
Multiple enablers and barriers were identified that may affect the implementation of evidence-based practice for the management of early pregnancy bleeding.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.